Delhi High Court Lifts Restrictions, Key Cancer Drug May Get Cheaper - 23.08.2019

Delhi High Court has suspended the interim relief granted to Novartis restraining the manufacture and sale of generic version of Ceritinib, launched by Natco Pharma. This move could help make the lung cancer drugs affordable.

Tags : Delhi High Court Cancer

Share :